Yumanity Therapeutics (FRA:8IY) Long-Term Debt : €0.00 Mil (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Long-Term Debt?

Yumanity Therapeutics's Long-Term Debt for the quarter that ended in Sep. 2022 was €0.00 Mil.

Yumanity Therapeutics's annual Long-Term Debt declined from Dec. 2019 (€13.02 Mil) to Dec. 2020 (€10.88 Mil) and declined from Dec. 2020 (€10.88 Mil) to Dec. 2021 (€6.51 Mil).

Yumanity Therapeutics Long-Term Debt Historical Data

The historical data trend for Yumanity Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Long-Term Debt Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Long-Term Debt

13.02

10.88

6.51

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Long-Term Debt	Get a 7-Day Free Trial							7.43	6.51	-	-	-

Yumanity Therapeutics (FRA:8IY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Yumanity Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines